Clinical Trials on Tremor Hereditary Essential, 1
Total 812 results
-
KU LeuvenCompletedParkinson Disease | Essential TremorBelgium
-
Abbott Medical DevicesCompletedParkinson's Disease | Essential TremorUnited States
-
Aleva Neurotherapeutics SACompletedParkinson's Disease | Essential TremorSwitzerland
-
Vanderbilt UniversityNational Parkinson Foundation; Robertson County Parkinson Support GroupTerminatedParkinson Disease | Essential TremorUnited States
-
Aleva Neurotherapeutics SATerminatedParkinson's Disease | Essential TremorSwitzerland
-
KU LeuvenCompletedParkinson Disease | Essential TremorBelgium
-
Washington University School of MedicineCompletedNeurofibromatosis Type 1 | Pediatric Brain TumorUnited States
-
ETH ZurichRecruitingEpilepsy | Parkinson Disease | Essential TremorSwitzerland
-
The Cleveland ClinicFarmer FoundationCompletedHealthy | Parkinson Disease | Essential Tremor | DBSUnited States
-
University Health Network, TorontoRecruitingParkinson Disease | Dystonia | Essential TremorCanada
-
Massachusetts General HospitalRecruitingParkinson Disease | Dystonia | Essential TremorUnited States
-
Westfälische Wilhelms-Universität MünsterCompletedParkinson Disease | Movement Disorders | Essential Tremor | Parkinson's Syndrome | Atypical ParkinsonismGermany
-
Mayo ClinicCompletedParkinson's Disease | Dystonia | Essential TremorUnited States
-
University Children's Hospital, ZurichCompletedParkinson's Disease | Dystonia | Essential TremorSwitzerland
-
Vanderbilt UniversityWithdrawnParkinson's Disease | Dystonia | Essential TremorUnited States
-
All India Institute of Medical Sciences, New DelhiNot yet recruiting
-
Boston Scientific CorporationRecruitingParkinson Disease | Dystonia | Essential TremorUnited States, Belgium, Germany
-
Assistance Publique Hopitaux De MarseilleCompletedPatients With Parkinson's DiseaseFrance
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaboratorsTerminatedNeurofibromatosis Type 1 (NF1)United States, Canada
-
Ophthalmos Research and Education InstituteCompletedStargardt Disease 1 | Dry AMDFrance, Germany, Italy
-
University of Alabama at BirminghamCompletedNeurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PNUnited States
-
Yonsei UniversityRecruitingEpilepsy | Parkinson Disease | Dystonia | Essential TremorKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingNeuroendocrine Neoplasm | Multiple Endocrine Neoplasia Type 1 | Advanced Carcinoid Tumor | Digestive System Neuroendocrine Neoplasm | Unresectable Carcinoid TumorUnited States
-
Pomeranian Medical University SzczecinUnknownRetinal Degeneration | Retinitis Pigmentosa | Age Related Macular Degeneration | Stargardt Disease 1Poland
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); Emory University and other collaboratorsEnrolling by invitationMultiple Sclerosis | Parkinson Disease | Dystonia | Essential TremorUnited States
-
Baodong QinUnknownChemotherapy Effect | Immunotherapy | Tumor Mutation Burden | PD-1/L1 InhibitorChina
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
Novartis PharmaceuticalsTerminatedPlexiform Neurofibroma Associated With Neurofibromatosis Type 1Israel
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingNeurofibromatosis Type 1 | Metastatic Malignant Peripheral Nerve Sheath Tumor | Recurrent Malignant Peripheral Nerve Sheath TumorUnited States
-
Ascidian Therapeutics, IncRecruitingStargardt Disease | Stargardt Disease 1 | Juvenile Macular Degeneration | Cone Rod DystrophyUnited States
-
Ascidian Therapeutics, IncRecruitingStargardt Disease | Stargardt Disease 1 | Juvenile Macular Degeneration | Cone Rod DystrophyUnited States
-
Yusuf MendaNational Cancer Institute (NCI); Holden Comprehensive Cancer Center; Perspective...Enrolling by invitationNeuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
AstraZenecaCompletedHealthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)United States
-
Alkeus Pharmaceuticals, Inc.RecruitingStargardt Disease | Stargardt Macular Degeneration | Stargardt Macular Dystrophy | Autosomal Recessive Stargardt Disease 1 (ABCA4-related)United States
-
Alkeus Pharmaceuticals, Inc.Enrolling by invitationStargardt Disease | Stargardt Macular Degeneration | Stargardt Macular Dystrophy | Autosomal Recessive Stargardt Disease 1 (ABCA4-related)United States
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Neurological Disorders and Stroke (NINDS); Children's...RecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | NF1United States
-
Guy's and St Thomas' NHS Foundation TrustRecruitingNeurofibromatosis Type 1United Kingdom
-
University Hospital, Strasbourg, FranceRecruitingNeurofibromatosis Type 1France
-
Donald BaselRecruiting
-
National Cancer Institute (NCI)CompletedNeurofibroma | Neurofibromatosis Type 1United States
-
Joergen SerupSahlgrenska University Hospital, SwedenActive, not recruitingCutaneous NeurofibromaDenmark, Sweden
-
Centre Leon BerardRecruitingNeurofibroma | Neurofibroma, PlexiformFrance
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis Type 1United States, Spain, Germany, Netherlands, Russian Federation, Italy, Japan
-
Shriners Hospitals for ChildrenCompletedNeurofibromatosis Type 1United States
-
Washington University School of MedicineCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
Guy's and St Thomas' NHS Foundation TrustCompletedNeurofibromatosis 1, NF1United Kingdom
-
KU LeuvenUnknownNeurofibromatosis Type 1Belgium
-
University of IowaNovartisRecruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
AstraZenecaRecruitingNeurofibromatosis Type 1Spain, United Kingdom, Israel, France, Italy, Portugal, Switzerland, Germany, Austria